Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter A van Doorn

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Journal of the Peripheral Nervous System : JPNS|August 21, 2009
What's new in Guillain-Barré syndrome in 2007-2008?Pieter A van Doorn
Journal of the Peripheral Nervous System : JPNS|June 17, 2005
Treatment of Guillain-Barré syndrome and CIDPPieter A van Doorn
Presse Medicale (Paris, France : 1983)|May 1, 2013
Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS)Pieter A van Doorn
Current Opinion in Neurology|September 16, 2004
Treatment of chronic inflammatory demyelinating polyneuropathyPieter A van Doorn, Liselotte Ruts
Drugs|June 6, 2009
Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathyKrista Kuitwaard, Pieter A van Doorn
Brain : a Journal of Neurology|May 29, 2016
Neuronal endocytosis of anti-ganglioside antibodies: implications for Guillain-Barré syndromePieter A van Doorn, Bart C Jacobs
The Lancet. Neurology|November 18, 2006
Predicting the course of Guillain-Barré syndromePieter A van Doorn, Bart C Jacobs
Neurology|April 26, 2024
Author Response: Age-Related Changes in Neurologic Examination and Sensory Nerve Amplitude in the General PopulationPieter A van Doorn, Noor E Taams
The Lancet. Neurology|January 30, 2004
Immunotherapy for Guillain-Barré syndromePieter A van Doorn, Rinske van Koningsveld
Current Opinion in Neurology|September 5, 2008
How to assess new drugs for neuropathies: advances in trial design and methodologyPieter A van Doorn, Ingemar S J Merkies
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Journal of the Peripheral Nervous System : JPNS|August 21, 2009
What's new in Guillain-Barré syndrome in 2007-2008?Pieter A van Doorn
Journal of the Peripheral Nervous System : JPNS|June 17, 2005
Treatment of Guillain-Barré syndrome and CIDPPieter A van Doorn
Presse Medicale (Paris, France : 1983)|May 1, 2013
Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS)Pieter A van Doorn
Current Opinion in Neurology|September 16, 2004
Treatment of chronic inflammatory demyelinating polyneuropathyPieter A van Doorn, Liselotte Ruts
Drugs|June 6, 2009
Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathyKrista Kuitwaard, Pieter A van Doorn
Brain : a Journal of Neurology|May 29, 2016
Neuronal endocytosis of anti-ganglioside antibodies: implications for Guillain-Barré syndromePieter A van Doorn, Bart C Jacobs
The Lancet. Neurology|November 18, 2006
Predicting the course of Guillain-Barré syndromePieter A van Doorn, Bart C Jacobs
Neurology|April 26, 2024
Author Response: Age-Related Changes in Neurologic Examination and Sensory Nerve Amplitude in the General PopulationPieter A van Doorn, Noor E Taams
The Lancet. Neurology|January 30, 2004
Immunotherapy for Guillain-Barré syndromePieter A van Doorn, Rinske van Koningsveld
Current Opinion in Neurology|September 5, 2008
How to assess new drugs for neuropathies: advances in trial design and methodologyPieter A van Doorn, Ingemar S J Merkies
Pageof 27